Search PubMed⌕ Search

Biomedical subjects

Damien Brégeon

Publications and source records attributed to Damien Brégeon.

4 recordsLinked to original sources

Assays for transcriptional mutagenesis in active genes.

Cells exposed to DNA-damaging agents in their natural environment do not undergo continuous cycles of replication but are more frequently engaged in gene transcription. Despite the relatively high efficiency of the different DNA repair pathways, some lesions remain in DNA. During transcription, RNA polymerase can bypass DNA damage on the transcribed strand of an active gene. This bypass can be at the origin of the production of "mutated" mRNA because of the transcriptional miscoding (transcriptional mutagenesis) due to the altered pairing specificities of the lesion. In vivo consequences of transcriptional mutagenesis on normal cell physiology have not well been documented because of the lack of a robust system allowing for its study. We describe here a procedure that we developed using a plasmid-based luciferase reporter assay to analyze the transcriptional mutagenesis events induced by different types of DNA lesions. Introduction of the DNA lesion to be studied at a specific site on the plasmid is based on the synthesis of a complementary strand of a circular, single-stranded DNA (ssDNA) from a DNA lesion-containing oligonucleotide. Once obtained, this construct can be transformed into different Escherichia coli strains that can express the luciferase gene under nongrowth conditions. Quantification of luciferase activity and sequencing of luciferase cDNAs allow for the characterization of transcriptional mutagenesis both quantitatively and qualitatively.

Base Sequence↗

Hypothetical role of RNA damage avoidance in preventing human disease.

Most of nucleic acids damaging agents are not only restricted to DNA but equally affect DNA and RNA molecules. Considering that RNA damage could be very toxic for the cell, a property used by some cancer treatments, it would not be unexpected to find out that several proteins may be involved in RNA damage avoidance mechanisms helping cells to counteract such cytotoxic effects. Up to now, only one specific repair mechanism allowing cells to deal with toxic effects of methylated RNA have been described. However, there are in the literature several data suggesting that this study may only be the tip of the iceberg and that cells might be able to counteract the deleterious effects of a large variety of RNA damage. In this review, we will discuss the different proteins that may be involved in the mechanism of RNA damage avoidance and their potential role in human diseases.

Alkylation↗

Reliable method for generating double-stranded DNA vectors containing site-specific base modifications.

Cells of all living organisms are continuously exposed to physical and chemical agents that damage DNA and alter the integrity of their genomes. Despite the relatively high efficiency of the different repair pathways, some lesions remain in DNA when it is replicated or transcribed. Lesion bypass by DNA and RNA polymerases has been the subject of numerous investigations. However, knowledge of the in vivo mechanism of transcription lesion bypass is very limited because no robust methodology is available. Here we describe a protocol based on the synthesis of a complementary strand of a circular, single-stranded DNA molecule, which allows for the production of large amounts of double-stranded DNA containing a lesion at a specific position in a transcribed sequence. Such constructs can subsequently be used for lesion bypass studies in vivo by RNA polymerase and to ascertain how these events can be affected by the genetic background of the cells.

Base Pair Mismatch↗

Transcriptional mutagenesis induced by uracil and 8-oxoguanine in Escherichia coli.

Cells exposed to DNA damaging agents in their natural environment do not undergo continuous cycles of replication but are more frequently engaged in gene transcription. Luciferase gene expression analysis with DNA templates containing uracil or 8-oxoguanine, placed at a defined position, indicated that in nondividing Escherichia coli cells, efficient mutagenic lesion bypass does occur in vivo during transcription. Sequence analyses of the transcript population revealed that RNA polymerase inserts adenine opposite to uracil, and adenine or cytosine opposite to 8-oxoguanine. Surprisingly, deletions were also detected for 8-oxoguanine-containing templates, indicating RNA polymerase slippage over this lesion. Genetic analyses showed that, in E. coli, 8-oxoguanine is subject to transcription-coupled repair. Consequently, DNA damages alter transcription fidelity in vivo, which may lead to the production of mutant proteins that have the potential to change the phenotype of nondividing cells.

Base Sequence↗